JPH09278653A - 網膜疾患治療剤 - Google Patents

網膜疾患治療剤

Info

Publication number
JPH09278653A
JPH09278653A JP8084205A JP8420596A JPH09278653A JP H09278653 A JPH09278653 A JP H09278653A JP 8084205 A JP8084205 A JP 8084205A JP 8420596 A JP8420596 A JP 8420596A JP H09278653 A JPH09278653 A JP H09278653A
Authority
JP
Japan
Prior art keywords
retinal
tranilast
occlusion
therapeutic agent
retinopathy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP8084205A
Other languages
English (en)
Japanese (ja)
Inventor
Norio Okamoto
紀夫 岡本
Kazuo Nishimura
和夫 西村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Priority to JP8084205A priority Critical patent/JPH09278653A/ja
Priority to PCT/JP1997/001120 priority patent/WO1997037650A1/fr
Publication of JPH09278653A publication Critical patent/JPH09278653A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
JP8084205A 1996-04-05 1996-04-05 網膜疾患治療剤 Withdrawn JPH09278653A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP8084205A JPH09278653A (ja) 1996-04-05 1996-04-05 網膜疾患治療剤
PCT/JP1997/001120 WO1997037650A1 (fr) 1996-04-05 1997-03-31 Medicaments contre les maladies retiniennes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8084205A JPH09278653A (ja) 1996-04-05 1996-04-05 網膜疾患治療剤

Publications (1)

Publication Number Publication Date
JPH09278653A true JPH09278653A (ja) 1997-10-28

Family

ID=13823993

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8084205A Withdrawn JPH09278653A (ja) 1996-04-05 1996-04-05 網膜疾患治療剤

Country Status (2)

Country Link
JP (1) JPH09278653A (fr)
WO (1) WO1997037650A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998047504A1 (fr) * 1997-04-18 1998-10-29 Kissei Pharmaceutical Co., Ltd. Remedes pour la prophylaxie ou le traitement de maladies se traduisant par une proliferation excessive des cellules epitheliales pigmentaires de la retine
JP4612981B2 (ja) * 1999-08-19 2011-01-12 キッセイ薬品工業株式会社 高血圧性細動脈障害抑制剤
JP2014502267A (ja) * 2010-11-24 2014-01-30 フィブロテック セラピューティクス プロプライエタリー リミテッド 炎症及び血管増殖に関連する眼疾患の治療法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006073126A1 (fr) * 2005-01-06 2006-07-13 Kissei Pharmaceutical Co., Ltd. Preventif et remede pour la keratoconjonctivite seche associee a la reaction de greffe contre hote
NZ574028A (en) 2006-07-05 2010-10-29 Fibrotech Therapeutics Pty Ltd Tranilast analogues (substituted cinnamoyl anthranilate compounds) for treatment of conditions associated with firbrosis
KR101593708B1 (ko) 2007-12-21 2016-02-12 피브로테크 세라퓨틱 피티와이 엘티디 항섬유증 제제의 할로겐화 유사체
WO2011047432A1 (fr) 2009-10-22 2011-04-28 Fibrotech Therapeutics Pty Ltd Analogues à cycles condensés d'agents anti-fibrotiques
CN110546133A (zh) 2017-02-03 2019-12-06 塞尔塔治疗有限公司 抗纤维化化合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60717B1 (en) * 1987-09-11 1994-08-10 Syntex Inc "Preservative system for ophthalmic formulations"
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
JPH01294620A (ja) * 1988-05-19 1989-11-28 Kissei Pharmaceut Co Ltd 水溶液製剤およびその製造方法
IT1224513B (it) * 1988-07-19 1990-10-04 Fidia Farmaceutici Uso terapeutico del derivato estere isopropilico del monosialogangliosi de in patologie ad interessamento nervoso con componente infiammatoria
JPH02289532A (ja) * 1989-02-27 1990-11-29 Takeda Chem Ind Ltd 生理活性物質ｔａｎ―１０８５，そのアグリコン，製造法及び用途
JPH07116029B2 (ja) * 1989-04-04 1995-12-13 キッセイ薬品工業株式会社 トラニラスト水溶液製剤
JPH0446120A (ja) * 1990-06-11 1992-02-17 Kyowa Hakko Kogyo Co Ltd 血管新生抑制剤
IL99683A0 (en) * 1990-10-12 1992-08-18 Merck Frosst Canada Inc Hydroxy alkylquinoline ether acids and pharmaceutical compositions containing them
JPH04279527A (ja) * 1991-01-18 1992-10-05 Otsuka Pharmaceut Co Ltd リジン又はアルギニン誘導体
ZA924953B (en) * 1991-07-25 1993-04-28 Univ Louisville Res Found Method of treating ocular inflammation
US5334597A (en) * 1991-10-17 1994-08-02 Merck Frosst Canada, Inc. Indole carbamates as leukotriene antagonists
DK196591D0 (da) * 1991-12-05 1991-12-05 Mouritsen & Elsner Aps Anvendelse af en kendt kemisk forbindelse til fremstilling af et farmaceutisk paraeparat til topisk applikation
JPH05163222A (ja) * 1991-12-18 1993-06-29 Kissei Pharmaceut Co Ltd コラーゲン過剰合成疾患治療剤
IT1252866B (it) * 1991-12-31 1995-06-28 Lifegroup Spa N-acilderivati di aminoalcooli con acidi policarbossilici atti alla modulazione dei mastociti nei processi infiammatori su base neuroimmunogenica
IT1252865B (it) * 1991-12-31 1995-06-28 Lifegroup Spa N-acilderivati di aminoalcooli attivi come autocoidi locali ed utilizzabili nella terapia dei processi autoimmuni
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998047504A1 (fr) * 1997-04-18 1998-10-29 Kissei Pharmaceutical Co., Ltd. Remedes pour la prophylaxie ou le traitement de maladies se traduisant par une proliferation excessive des cellules epitheliales pigmentaires de la retine
JP4612981B2 (ja) * 1999-08-19 2011-01-12 キッセイ薬品工業株式会社 高血圧性細動脈障害抑制剤
JP2014502267A (ja) * 2010-11-24 2014-01-30 フィブロテック セラピューティクス プロプライエタリー リミテッド 炎症及び血管増殖に関連する眼疾患の治療法
US9839640B2 (en) 2010-11-24 2017-12-12 Occurx Pty Ltd Methods of treating eye diseases associated with inflammation and vascular proliferation
US10695353B2 (en) 2010-11-24 2020-06-30 Occurx Pty Ltd Methods of treating eye diseases associated with inflammation and vascular proliferation
US10786510B2 (en) 2010-11-24 2020-09-29 Occurx Pty Ltd Methods of treating eye diseases associated with inflammation and vascular proliferation
US11583535B2 (en) 2010-11-24 2023-02-21 Occurx Pty Ltd Methods of treating eye diseases associated with inflammation and vascular proliferation

Also Published As

Publication number Publication date
WO1997037650A1 (fr) 1997-10-16

Similar Documents

Publication Publication Date Title
TWI260327B (en) Pharmaceutical compositions for treating ocular neovascular diseases
JP5579079B2 (ja) 黄斑浮腫治療用ジフルプレドナート点眼剤
JPH0468288B2 (fr)
JP2005104862A (ja) 加齢黄斑変性治療剤
Coppeto et al. Neovascular glaucoma and carotid artery obstructive disease
Klais et al. Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children
JPH09278653A (ja) 網膜疾患治療剤
RU2297813C1 (ru) Способ лечения неоваскулярной глаукомы
AU761092B2 (en) Use of staurosporine derivatives for treating ocular neovascular diseases
US20030007971A1 (en) Remedies for ophthalmic diseases
WO2000021531A1 (fr) Medicaments pour maladies oculaires
RU2489146C1 (ru) Способ лечения "сухой" формы возрастной макулярной дегенерации
ES2324200T3 (es) Medicamentos oftalmologicos retino-protectores, que comprenden ramipril o ramiprilato.
EP0565897B1 (fr) Composés de l'argatroban pour utilisation ophthalmologique
US6605640B2 (en) Method of treating certain eye diseases
JP2004331502A (ja) 視神経細胞保護剤
CA2398900A1 (fr) Agents therapeutiques pour troubles ophtalmiques
JP3530542B2 (ja) 眼科用アルガトロバン製剤
JP4393863B2 (ja) 視神経細胞保護剤
WO2008023784A1 (fr) Agent pour l'amélioration d'un trouble de la circulation ophtalmique
US20040259844A1 (en) Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage
RU2411033C1 (ru) Способ лечения глаукомной оптической нейропатии в пожилом и старом возрасте
Kulshrestha et al. The role of preoperative subconjunctival mydricaine and topical diclofenac sodium 0.1% in maintaining mydriasis during vitrectomy
KR20030087029A (ko) 스테로이드를 유효 성분으로 하는 망맥락막 질환 치료제
JP2002154985A (ja) 眼疾患治療剤

Legal Events

Date Code Title Description
A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20030701